Medicine and Dentistry
Estrogen Receptor Beta
100%
Ovarian Cancer
76%
Beta Adrenergic Receptor Stimulating Agent
61%
Assay
23%
Neoplasm
15%
Cancer Cell
15%
Combination Therapy
15%
Programmed Cell Death
15%
Immunoprecipitation
15%
Anti-Inflammatory Drug
15%
Diseases
7%
down Regulation
7%
Ligand
7%
Estrogen
7%
Xenograft
7%
Paclitaxel
7%
Cisplatin
7%
Long Term Survival
7%
Cancer Growth
7%
Biological Activity
7%
Tumor Progression
7%
Estrogen Receptor Alpha
7%
Growth Inhibition
7%
Therapeutic Agent
7%
Cell Viability
7%
Alpha Adrenergic Receptor
7%
Cell Survival
7%
Development
7%
Cancer Model
7%
Daidzein
7%
Female Genital Tract Cancer
7%
Gene
7%
Glycyrrhiza Uralensis
7%
Liquiritigenin
7%
Analysis
7%
Cells
7%
Therapeutic Procedure
7%
Patient
7%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor Beta
100%
Ovary Cancer
76%
Beta Adrenergic Receptor Stimulating Agent
61%
Chemotherapy
30%
Neoplasm
15%
Tumor Suppressor Protein
15%
Diseases
7%
Ligand
7%
Cisplatin
7%
Paclitaxel
7%
Estrogen
7%
Tumor Growth
7%
Alpha Adrenergic Receptor
7%
Cancer Growth
7%
Long Term Survival
7%
Estrogen Receptor Alpha
7%
Cancer Model
7%
Female Genital Tract Cancer
7%
Glycyrrhiza Uralensis
7%
Liquiritigenin
7%
Daidzein
7%